Children Hard Capsule Softgel Capsule

Name: Children Hard Capsule Softgel Capsule
Brand: Shandong Yuwang Pharmaceutical Co., Ltd.
SKU: 730263982

Shandong, ChinaShandong Yuwang Pharmaceutical Co., Ltd.

US$0.035

100,000-499,999 Pieces

US$0.033

500,000+ Pieces

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Function

Cosmetology, Lowering Blood Pressure

Certification

GMP, ISO, HACCP, QS, FDA

Model NO.

YWQD-251

Age Group

Adults

Type

Capsule

Gender

Unisex

Feature

Organic, Vitamins, Low-Fat

Packaging

Bottle

Storage Note

Moisture Proof

Logo Printing

Without Logo Printing

Product Type

Food

Health Food Approval No.

GMP2007054

Transport Package

Carton

Specification

500mg, 1000mg softgel

Trademark

OEM

Origin

China

HS Code

2106909090

Production Capacity

30 Billion Per Year

Company profile

Shandong Yuwang Pharmaceutical Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2000-09-01 CertifiedNearest Port: Qingdao PortAverage Response Time: ≤1.67h CertifiedTerms of Payment: LC, T/T

AI-Powered supplier vetting

SummaryShandong Yuwang Pharmaceutical Co., Ltd., established in 1994 in Shandong, China, is a manufacturer specializing in health products like fish oil capsules. The company holds ISO9001:2015, ISO14001:2015, and ISO45001:2016 certifications, indicating a commitment to quality and environmental standards. With over 10 production lines and an annual capacity of 10 billion capsules, it exports 51%-70% of its products, mainly to South America, Europe, and North America. The company emphasizes quality and innovation, with a focus on export markets since 2000.

Supplier typeShandong Yuwang Pharmaceutical Co., Ltd. is a manufacturer located in Shandong, China, specializing in health and pharmaceutical products.

CertificationsThe company holds ISO9001:2015, ISO14001:2015, and ISO45001:2016 certifications, which reflect adherence to quality management, environmental management, and occupational health and safety standards.

Financial creditThe company began exporting in 2000 and generates a significant portion of sales from exports, with an annual production output exceeding US$100 million.

R&D capabilityThe company focuses on continuous improvement and innovation, as stated in their quality objectives and commitment to compete in international markets.

Production capacityThe company has over 10 production lines, a large manufacturing plant area, and an annual production capacity of 10 billion capsules, indicating strong production capabilities.

Client casesThe company has transactions with international clients like CÔNG TY CỔ PHẦN DƯỢC PHẨM AMPHARCO U S A, indicating its active engagement in global markets.